Cellular immunity and immunopathology in autoimmune Addison's disease

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 180-190

  Bratland, Eirik ^a,b   Husebye, Eystein S ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

21 Hydroxylase; Addison's disease; Adrenal cortex; Adrenalitis; Autoimmunity

Indexed keywords

AUTOANTIBODY; COMPLEMENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA ANTIGEN; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 1BETA; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROGRAMMED DEATH 1 LIGAND 1; STEROID 17ALPHA MONOOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADDISON DISEASE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EFFECTOR CELL; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ADDISON DISEASE; ANIMALS; ANTIGENS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; MODELS, IMMUNOLOGICAL;

EID: 79952070503     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.12.015     Document Type: Review

References (135)

1. Addison T. On the Constitutional and Local Effects of Disease of the Suprarenal Capsules 1855, Samuel Highley, London.
2. Ahonen P., Myllarniemi S., Sipila I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 1990, 322:1829-1836.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Alli R., Nguyen P., Geiger T.L. Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J. Immunol. 2008, 181:136-145.
5. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401.
6. Andrada J.A., Skelton F.R., Andrada E.C., Milgrom F., Witebsky E. Experimental autoimmune adrenalitis in rats. Lab. Invest. 1968, 19:460-465.
7. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
8. Arlt W., Allolio B. Adrenal insufficiency. Lancet 2003, 361:1881-1893.
9. Baker P.R., Baschal E.E., Fain P.R., Triolo T.M., Nanduri P., Siebert J.C., Armstrong T.K., Babu S.R., Rewers M.J., Gottlieb P.A., Barker J.M., Eisenbarth G.S. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J. Clin. Endocrinol. Metab. 2010, 95:E263-270.
10. Barnett E.V., Dumonde D.C., Glynn L.E. Induction of autoimmunity to adrenal gland. Immunology 1963, 6:382-402.
11. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
12. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
13. Betterle C., Dal Pra C., Mantero F., Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 2002, 23:327-364.
14. Betterle C., Scalici C., Presotto F., Pedini B., Moro L., Rigon F., Mantero F. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J. Endocrinol. 1988, 117:467-475.
15. Betterle C., Zanette F., Zanchetta R., Pedini B., Trevisan A., Mantero F., Rigon F. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet 1983, 1:1238-1241.
16. Blizzard R.M., Kyle M. Studies of the adrenal antigens and antibodies in Addison's disease. J. Clin. Invest. 1963, 42:1653-1660.
17. Blomhoff A., Lie B.A., Myhre A.G., Kemp E.H., Weetman A.P., Akselsen H.E., Huseby E.S., Undlien D.E. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 2004, 89:3474-3476.
18. Boe Wolff A.S., Oftedal B., Johansson S., Bruland O., Lovas K., Meager A., Pedersen C., Husebye E.S., Knappskog P.M. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes Immun. 2008, 9:130-136.
19. Bornstein S.R., Chrousos G.P. Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J. Clin. Endocrinol. Metab. 1999, 84:1729-1736.
20. Bornstein S.R., Rutkowski H., Vrezas I. Cytokines and steroidogenesis. Mol. Cell. Endocrinol. 2004, 215:135-141.
21. Bornstein S.R., Ziegler C.G., Krug A.W., Kanczkowski W., Rettori V., McCann S.M., Wirth M., Zacharowski K. The role of toll-like receptors in the immune-adrenal crosstalk. Ann. N. Y. Acad. Sci. 2006, 1088:307-318.
22. Boscaro M., Betterle C., Volpato M., Fallo F., Furmaniak J., Rees Smith B., Sonino N. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J. Clin. Endocrinol. Metab. 1996, 81:2801-2804.
23. Brand O., Gough S., Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?. Expert Rev. Mol. Med. 2005, 7:1-15.
24. Bratland E., Skinningsrud B., Undlien D.E., Mozes E., Husebye E.S. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 2009, 94:5117-5124.
25. Brown-Séquard C.E. Recherches expérimentales sur la physiologie et la pathologie des capsules surrénales. C. R. Acad. Sci. 1856, 43:422-425.
26. Calderon B., Suri A., Miller M.J., Unanue E.R. Dendritic cells in islets of langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6121-6126.
27. Carpenter C.C., Solomon N., Silverberg S.G., Bledsoe T., Northcutt R.C., Klinenberg J.R., Bennett I.L., Harvey A.M. Schmidt's syndrome (thyroid and adrenal insufficiency). A review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine (Baltimore) 1964, 43:153-180.
28. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002, 51:1383-1390.
29. Colover J., Glynn L.E. Experimental iso-immune adrenalitis. Immunology 1958, 1:172-178.
30. Dechairo B.M., Zabaneh D., Collins J., Brand O., Dawson G.J., Green A.P., Mackay I., Franklyn J.A., Connell J.M., Wass J.A., Wiersinga W.M., Hegedus L., Brix T., Robinson B.G., Hunt P.J., Weetman A.P., Carey A.H., Gough S.C. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur. J. Hum. Genet. 2005, 13:1223-1230.
31. Devendra D., Eisenbarth G.S. 17. Immunologic endocrine disorders. J. Allergy Clin. Immunol. 2003, 111:S624-636.
32. Drury M.I., Keelan D.M., Timoney F.J., Irvine W.J. Juvenile familial endocrinopathy. Clin. Exp. Immunol. 1970, 7:125-132.
33. Durinovic-Bello I., Wu R.P., Gersuk V.H., Sanda S., Shilling H.G., Nepom G.T. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun. 2010, 11:188-193.
34. Eizirik D.L., Mandrup-Poulsen T. A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44:2115-2133.
35. Erichsen M.M., Lovas K., Skinningsrud B., Wolff A.B., Undlien D.E., Svartberg J., Fougner K.J., Berg T.J., Bollerslev J., Mella B., Carlson J.A., Erlich H., Husebye E.S. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 2009, 94:4882-4890.
36. Figueroa-Vega N., Alfonso-Perez M., Benedicto I., Sanchez-Madrid F., Gonzalez-Amaro R., Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 2010, 95:953-962.
37. Finnish-German APECED Consortium An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 1997, 17:399-403.
38. Freeman M., Weetman A.P. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin. Exp. Immunol. 1992, 88:275-279.
39. Fujii Y., Kato N., Kito J., Asai J., Yokochi T. Experimental autoimmune adrenalitis: a murine model for Addison's disease. Autoimmunity 1992, 12:47-52.
40. Furmaniak J., Kominami S., Asawa T., Wedlock N., Colls J., Smith B.R. Autoimmune Addison's disease - evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J. Clin. Endocrinol. Metab. 1994, 79:1517-1521.
41. Gambelunghe G., Falorni A., Ghaderi M., Laureti S., Tortoioli C., Santeusanio F., Brunetti P., Sanjeevi C.B. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 1999, 84:3701-3707.
42. Gastone G.N. Introduction to histology of the mammalian adrenal cortex. Microsc. Res. Tech. 1997, 36:443-444.
43. Gattoni A., Parlato A., Vangieri B., Bresciani M., Derna R. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts). Clin. Ter. 2006, 157:457-468.
44. Ghaderi M., Gambelunghe G., Tortoioli C., Brozzetti A., Jatta K., Gharizadeh B., De Bellis A., Pecori Giraldi F., Terzolo M., Betterle C., Falorni A. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 2006, 91:4107-4111.
45. Gombos Z., Hermann R., Kiviniemi M., Nejentsev S., Reimand K., Fadeyev V., Peterson P., Uibo R., Ilonen J. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur. J. Endocrinol. 2007, 157:757-761.
46. Goodnow C.C. Multistep pathogenesis of autoimmune disease. Cell 2007, 130:25-35.
47. Goudie R.B., McDonald E., Anderson J.R., Gray K. Immunological features of idiopathic Addison's disease: characterization of the adrenocortical antigens. Clin. Exp. Immunol. 1968, 3:119-131.
48. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30:1205-1213.
49. Hammer J., Gallazzi F., Bono E., Karr R.W., Guenot J., Valsasnini P., Nagy Z.A., Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 1995, 181:1847-1855.
50. Hill N.J., Hultcrantz M., Sarvetnick N., Flodstrom-Tullberg M. The target tissue in autoimmunity - an influential niche. Eur. J. Immunol. 2007, 37:589-597.
51. Holst J., Szymczak-Workman A.L., Vignali K.M., Burton A.R., Workman C.J., Vignali D.A. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 2006, 1:406-417.
52. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., Knip M., Otonkoski T., Vaarala O. IL-17 immunity in human type 1 diabetes. J. Immunol. 2010, 185:1959-1967.
53. Husebye E.S., Perheentupa J., Rautemaa R., Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 2009, 265:514-529.
54. Imam K., Abdullah M., Felicetta J.V. Alopecia universalis as a feature of polyglandular autoimmunity type I. West J. Med. 1988, 149:338-341.
55. Irino T., Grollman A. Induction of adrenal insufficiency in the rat by sensitization with homologous tissue. Metabolism 1968, 17:717-724.
56. Irvine W.J., Chan M.M., Scarth L., Kolb F.O., Hartog M., Bayliss R.I., Drury M.I. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1968, 2:883-887.
57. Irvine W.J., Stewart A.G., Scarth L. A clinical and immunological study of adrenocortical insufficiency (Addison's disease). Clin. Exp. Immunol. 1967, 2:31-70.
58. Jackson R., McNicol A.M., Farquharson M., Foulis A.K. Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison's disease. J. Pathol. 1988, 155:113-120.
59. Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J. Autoimmun. 2007, 28:85-98.
60. Kabel P.J., Voorbij H.A., De Haan M., van der Gaag R.D., Drexhage H.A. Intrathyroidal dendritic cells. J. Clin. Endocrinol. Metab. 1988, 66:199-207.
61. Kanczkowski W., Zacharowski K., Wirth M.P., Ehrhart-Bornstein M., Bornstein S.R. Differential expression and action of Toll-like receptors in human adrenocortical cells. Mol. Cell. Endocrinol. 2009, 300:57-65.
62. Kekalainen E., Tuovinen H., Joensuu J., Gylling M., Franssila R., Pontynen N., Talvensaari K., Perheentupa J., Miettinen A., Arstila T.P. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Immunol. 2007, 178:1208-1215.
63. Khoury E.L., Greenspan J.S., Greenspan F.S. Adrenocortical cells of the zona reticularis normally express HLA-DR antigenic determinants. Am. J. Pathol. 1987, 127:580-591.
64. Kisand K., Boe Wolff A.S., Podkrajsek K.T., Tserel L., Link M., Kisand K.V., Ersvaer E., Perheentupa J., Erichsen M.M., Bratanic N., Meloni A., Cetani F., Perniola R., Ergun-Longmire B., Maclaren N., Krohn K.J., Pura M., Schalke B., Strobel P., Leite M.I., Battelino T., Husebye E.S., Peterson P., Willcox N., Meager A. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 2010, 207:299-308.
65. Kisand K., Link M., Wolff A.S., Meager A., Tserel L., Org T., Murumagi A., Uibo R., Willcox N., Trebusak Podkrajsek K., Battelino T., Lobell A., Kampe O., Lima K., Meloni A., Ergun-Longmire B., Maclaren N.K., Perheentupa J., Krohn K.J., Scott H.S., Husebye E.S., Peterson P. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood 2008, 112:2657-2666.
66. Kita H., Lian Z.X., Van de Water J., He X.S., Matsumura S., Kaplan M., Luketic V., Coppel R.L., Ansari A.A., Gershwin M.E. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 2002, 195:113-123.
67. Kriegel M.A., Lohmann T., Gabler C., Blank N., Kalden J.R., Lorenz H.M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 2004, 199:1285-1291.
68. Krohn K., Uibo R., Aavik E., Peterson P., Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet 1992, 339:770-773.
69. Laureti S., De Bellis A., Muccitelli V.I., Calcinaro F., Bizzarro A., Rossi R., Bellastella A., Santeusanio F., Falorni A. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J. Clin. Endocrinol. Metab. 1998, 83:3507-3511.
70. Levine S., Wenk E.J. The production and passive transfer of allergic adrenalitis. Am. J. Pathol. 1968, 52:41-54.
71. Li Y., Huang Y., Lue J., Quandt J.A., Martin R., Mariuzza R.A. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 2005, 24:2968-2979.
72. Lo D., Reilly C.R., Scott B., Liblau R., McDevitt H.O., Burkly L.C. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur. J. Immunol. 1993, 23:1693-1698.
73. Lopez E.R., Zwermann O., Segni M., Meyer G., Reincke M., Seissler J., Herwig J., Usadel K.H., Badenhoop K. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis. Graves' disease and type 1 diabetes mellitus in Germans. Eur. J. Endocrinol. 2004, 151:193-197.
74. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 1998, 188:1493-1501.
75. Ludwig H., Eibl M., Schernthaner G., Mayr W.R. Cellular and humoral immunity to adrenal antigens in patients with idiopathic Addison's disease. Z Immunitatsforsch Immunobiol. 1976, 152:179-189.
76. Maclaren N.K., Riley W.J. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrinol. Metab. 1986, 62:455-459.
77. Magitta N.F., Boe Wolff A.S., Johansson S., Skinningsrud B., Lie B.A., Myhr K.M., Undlien D.E., Joner G., Njolstad P.R., Kvien T.K., Forre O., Knappskog P.M., Husebye E.S. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun. 2009, 10:120-124.
78. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009, 39:216-224.
79. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
80. Marx C., Bornstein S.R., Wolkersdorfer G.W. Cellular immune-endocrine interaction in adrenocortical tissues. Eur. J. Clin. Invest. 2000, 30(Suppl. 3):1-5.
81. Marx C., Ehrhart-Bornstein M., Scherbaum W.A., Bornstein S.R. Regulation of adrenocortical function by cytokines - relevance for immune-endocrine interaction. Horm. Metab. Res. 1998, 30:416-420.
82. Meager A., Visvalingam K., Peterson P., Moll K., Murumagi A., Krohn K., Eskelin P., Perheentupa J., Husebye E., Kadota Y., Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006, 3:e289.
83. Meloni A., Furcas M., Cetani F., Marcocci C., Falorni A., Perniola R., Pura M., Boe Wolff A.S., Husebye E.S., Lilic D., Ryan K.R., Gennery A.R., Cant A.J., Abinun M., Spickett G.P., Arkwright P.D., Denning D., Costigan C., Dominguez M., McConnell V., Willcox N., Meager A. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 2008, 93:4389-4397.
84. Michels A.W., Eisenbarth G.S. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2). J. Intern. Med. 2009, 265:530-540.
85. Mitchell A.L., Cordell H.J., Soemedi R., Owen K., Skinningsrud B., Wolff A.B., Ericksen M., Undlien D., Husebye E., Pearce S.H. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 2009, 94:5139-5145.
86. Myhre A.G., Undlien D.E., Lovas K., Uhlving S., Nedrebo B.G., Fougner K.J., Trovik T., Sorheim J.I., Husebye E.S. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 2002, 87:618-623.
87. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., Shimizu N. Positional cloning of the APECED gene. Nat. Genet. 1997, 17:393-398.
88. Nerup J., Andersen V., Bendixen G. Anti-adrenal, cellular hypersensitivity in Addison's disease. Clin. Exp. Immunol. 1969, 4:355-363.
89. Nerup J., Andersen V., Bendixen G. Anti-adrenal cellular hypersensitivity in Addison's disease. IV. In vivo and in vitro investigations on the mitochondrial fraction. Clin. Exp. Immunol. 1970, 6:733-739.
90. Nerup J., Bendixen G. Anti-adrenal cellular hypersensitivity in Addison's disease. II. Correlation with clinical and serological findings. Clin. Exp. Immunol. 1969, 5:341-353.
91. Nerup J., Bendixen G. Anti-adrenal cellular hypersensitivity in Addison's disease. III. Species-specificity and subcellular localization of the antigen. Clin. Exp. Immunol. 1969, 5:355-364.
92. Pani M.A., Seissler J., Usadel K.H., Badenhoop K. Vitamin D receptor genotype is associated with Addison's disease. Eur. J. Endocrinol. 2002, 147:635-640.
93. Park Y.S., Sanjeevi C.B., Robles D., Yu L., Rewers M., Gottlieb P.A., Fain P., Eisenbarth G.S. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 2002, 60:155-163.
94. Partanen J., Peterson P., Westman P., Aranko S., Krohn K. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum. Immunol. 1994, 41:135-140.
95. Patnaik M.M., Deshpande A.K. Diagnosis - Addison's disease secondary to tuberculosis of the adrenal glands. Clin. Med. Res. 2008, 6:29.
96. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol. Metab. Clin. North Am. 2002, 31:295-320.
97. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 2006, 91:2843-2850.
98. Peterson P., Partanen J., Aavik E., Salmi H., Pelkonen R., Krohn K.J. Steroid 21-hydroxylase gene polymorphism in Addison's disease patients. Tissue Antigens 1995, 46:63-67.
99. Peterson P., Uibo R., Peranen J., Krohn K. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21. Clin. Exp. Immunol. 1997, 107:335-340.
100. Puel A., Doffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachee-Chardin M., Toulon A., Bustamante J., Al-Muhsen S., Al-Owain M., Arkwright P.D., Costigan C., McConnell V., Cant A.J., Abinun M., Polak M., Bougneres P.F., Kumararatne D., Marodi L., Nahum A., Roifman C., Blanche S., Fischer A., Bodemer C., Abel L., Lilic D., Casanova J.L. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 2010, 207:291-297.
101. Pugliese A., Zeller M., Fernandez A., Zalcberg L.J., Bartlett R.J., Ricordi C., Pietropaolo M., Eisenbarth G.S., Bennett S.T., Patel D.D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 1997, 15:293-297.
102. Quaratino S., Badami E., Pang Y.Y., Bartok I., Dyson J., Kioussis D., Londei M., Maiuri L. Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat. Med. 2004, 10:920-926.
103. Quaratino S., Ruf J., Osman M., Guo J., McLachlan S., Rapoport B., Londei M. Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope. J. Immunol. 2005, 174:557-563.
104. Reijonen H., Daniels T.L., Lernmark A., Nepom G.T. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 2000, 49:1621-1626.
105. Rosenthal F.D., Davies M.K., Burden A.C. Malignant disease presenting as Addison's disease. Br. Med. J. 1978, 1:1591-1592.
106. Rotondi M., Chiovato L., Romagnani S., Serio M., Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocr. Rev. 2007, 28:492-520.
107. Rotondi M., Falorni A., De Bellis A., Laureti S., Ferruzzi P., Romagnani P., Buonamano A., Lazzeri E., Crescioli C., Mannelli M., Santeusanio F., Bellastella A., Serio M. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J. Clin. Endocrinol. Metab. 2005, 90:2357-2363.
108. Rottembourg D., Deal C., Lambert M., Mallone R., Carel J.C., Lacroix A., Caillat-Zucman S., le Deist F. 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J. Autoimmun. 2010, 35:309-315.
109. Roycroft M., Fichna M., McDonald D., Owen K., Zurawek M., Gryczynska M., Januszkiewicz-Lewandowska D., Fichna P., Cordell H., Donaldson P., Nowak J., Pearce S. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin. Endocrinol. (Oxf) 2009, 70:358-362.
110. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
111. Sato T. Class II MHC-expressing cells in the rat adrenal gland defined by monoclonal antibodies. Histochem. Cell Biol. 1998, 109:359-367.
112. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., Blank M., Zandman-Goddard G., Katz U., Krause I., Langevitz P., Levy Y., Orbach H., Pordeus V., Ram M., Sherer Y., Toubi E., Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases - 2008. Isr. Med. Assoc. J. 2008, 10:3-7.
113. Skinningsrud B., Husebye E.S., Gervin K., Lovas K., Blomhoff A., Wolff A.B., Kemp E.H., Egeland T., Undlien D.E. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur. J. Hum. Genet. 2008, 16:977-982.
114. Skinningsrud B., Husebye E.S., Pearce S.H., McDonald D.O., Brandal K., Wolff A.B., Lovas K., Egeland T., Undlien D.E. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 2008, 93:3310-3317.
115. Skoskiewicz M.J., Colvin R.B., Schneeberger E.E., Russell P.S. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J. Exp. Med. 1985, 162:1645-1664.
116. Soderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., Miettinen A., Eskelin P., Halonen M., Tuomi T., Gustafsson J., Husebye E.S., Perheentupa J., Gylling M., Manns M.P., Rorsman F., Kampe O., Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 2004, 89:557-562.
117. Sotsiou F., Bottazzo G.F., Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin. Exp. Immunol. 1980, 39:97-111.
118. Spies T. Induction of T cell alertness by bacterial colonization of intestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2584-2586.
119. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., Marrack P., Mahata S.K., Kappler J.W., Haskins K. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 2010, 11:225-231.
120. Stadinski B.D., Zhang L., Crawford F., Marrack P., Eisenbarth G.S., Kappler J.W. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A 2010, 107:10978-10983.
121. Steiner J.W., Langer B., Schatz D.L., Volpe R. Experimental immunologic adrenal injury: a response to injections of autologous and homologous adrenal antigens in adjuvant. J. Exp. Med. 1960, 112:187-202.
122. Stephens H.A. MICA and MICB genes: can the enigma of their polymorphism be resolved?. Trends Immunol. 2001, 22:378-385.
123. Todd I., Pujol-Borrell R., Hammond L.J., Bottazzo G.F., Feldmann M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin. Exp. Immunol. 1985, 61:265-273.
124. Triolo T.M., Baschal E.E., Armstrong T.K., Toews C.S., Fain P.R., Rewers M.J., Yu L., Miao D., Eisenbarth G.S., Gottlieb P.A., Barker J.M. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 2009, 94:4517-4523.
125. Uibo R., Aavik E., Peterson P., Perheentupa J., Aranko S., Pelkonen R., Krohn K.J. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J. Clin. Endocrinol. Metab. 1994, 78:323-328.
126. Vaidya B., Imrie H., Geatch D.R., Perros P., Ball S.G., Baylis P.H., Carr D., Hurel S.J., James R.A., Kelly W.F., Kemp E.H., Young E.T., Weetman A.P., Kendall-Taylor P., Pearce S.H. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 2000, 85:688-691.
127. van Etten E., Verlinden L., Giulietti A., Ramos-Lopez E., Branisteanu D.D., Ferreira G.B., Overbergh L., Verstuyf A., Bouillon R., Roep B.O., Badenhoop K., Mathieu C. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 2007, 37:395-405.
128. Voorby H.A., Kabel P.J., de Haan M., Jeucken P.H., van der Gaag R.D., de Baets M.H., Drexhage H.A. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin. Immunol. Immunopathol. 1990, 55:9-22.
129. Winqvist O., Gustafsson J., Rorsman F., Karlsson F.A., Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 1993, 92:2377-2385.
130. Winqvist O., Karlsson F.A., Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992, 339:1559-1562.
131. Wolkersdorfer G.W., Lohmann T., Marx C., Schroder S., Pfeiffer R., Stahl H.D., Scherbaum W.A., Chrousos G.P., Bornstein S.R. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction. J. Clin. Endocrinol. Metab. 1999, 84:4220-4227.
132. Wolkersdorfer G.W., Marx C., Brown J., Schroder S., Fussel M., Rieber E.P., Kuhlisch E., Ehninger G., Bornstein S.R. Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2005, 90:1768-1774.
133. Wucherpfennig K.W., Call M.J., Deng L., Mariuzza R. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr. Opin. Immunol. 2009, 21:590-595.
134. Yu L., Brewer K.W., Gates S., Wu A., Wang T., Babu S.R., Gottlieb P.A., Freed B.M., Noble J., Erlich H.A., Rewers M.J., Eisenbarth G.S. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J. Clin. Endocrinol. Metab. 1999, 84:328-335.
135. Zurawek M., Fichna M., Januszkiewicz-Lewandowska D., Gryczynska M., Fichna P., Nowak J. A coding variant in NLRP1 is associated with autoimmune Addison's disease. Hum. Immunol. 2010, 71:530-534.